ABSTRACT Aim To evaluate the association between preoperative neoadjuvant therapy and short‐term outcomes of transanal total mesorectal excision for rectal cancer. Methods We retro
ABSTRACT Inflammatory bowel disease management has undergone a major transformation with the introduction of treat‐to‐target strategies and highly effective biologic and small‐mole
A retrospective cohort study with adequate sample size and long follow-up (median 63 months) reporting a clinically meaningful primary endpoint (delayed re-stoma-free survival), but lacks a comparator group and prospective design; results support the durability of sphincter-preserving surgery but require confirmation in prospective studies.